Abstract

Background: The measurement of health-related quality of life (HRQoL) provides utility scores that could be used for health economics assessment. The aim of this study was to measure HRQoL in Lebanese patients with certain medical conditions, and to determine demographic and medical factors affecting such health utility scores. Method: This was a prospective cross-sectional pilot study conducted to gather information on the socioeconomic status, health condition and quality of life of participants with common diseases during their community pharmacy visit. The EuroQol-5-Dimension instrument was used to measure utility scores and SPSS v26 was used to perform the statistical analysis. Results: Participants (n = 102) gave an average of 6.8 and 7.4 out of 10 for their current health and for their satisfaction with their treatment, respectively. The mean utility score was 0.762 (SD 0.202). The number of prescribed medications per respondent indicated a significant impact on HRQoL (p = 0.002). On average, the utility scores were low for participants who were 75 years or older (0.15, p < 0.001), and those who were hospitalized in the past 12 months (0.111, p < 0.001). For every unit increase in treatment satisfaction, the quality-of-life score increased by 0.036 unit (p = 0.001). Conclusion: This pilot study measured health utility scores and factors influencing HRQoL in the Lebanese population. Further studies are needed to confirm our findings and to develop and validate tools helping to measure health related quality of life in the population in Lebanon.

Highlights

  • The competitive global market place has increasingly acknowledged the usefulness of health-related quality of life (HRQoL) data to assist policy makers in reimbursement decisions by identifying the best alternative option among innovative medicines [1]

  • EuroQol 5 Dimension (EQ-5D-5L) is an instrument used to evaluate the generic quality of life developed in Europe and is a preference-based HRQoL measure

  • 82.4% were above 50 years of age and 77.8% of the respondents were living with their families

Read more

Summary

Introduction

The competitive global market place has increasingly acknowledged the usefulness of health-related quality of life (HRQoL) data to assist policy makers in reimbursement decisions by identifying the best alternative option among innovative medicines [1]. EuroQol 5 Dimension (EQ-5D-5L) is an instrument used to evaluate the generic quality of life developed in Europe and is a preference-based HRQoL measure. This descriptive instrument has five questions each addressing one of the following five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, which are common problems in patients with chronic diseases [2]. Method: This was a prospective cross-sectional pilot study conducted to gather information on the socioeconomic status, health condition and quality of life of participants with common diseases during their community pharmacy visit.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call